Catalog

Clinical Dialogues are video-based moderated discussions featuring leading experts providing the latest patient management guidelines. eCase Challenges are interactive text or or video-based cases where PAs are presented with challenging case scenarios a

JAAPA CME post-tests are available in AAPA's monthly clinical journal or online.

An Update on Treatments for Autosomal Dominant Polycystic Kidney Disease | An Overview of Myelodysplastic Syndromes

Diagnosing and Managing Adrenal Incidentalomas | Fecal Impaction in Adults

This is an 8 hour training course for physicians and physician assistants who wish to prescribe buprenorphine to treat opioid use disorder (OUD). This training will satisfy the 8 hour training requirement mandated by the MATE Act.

This series counts toward the new Drug Enforcement Administration (DEA) requirement for PAs treating and managing opioid use disorder (OUD) and substance use disorder (SUD). The series focuses on alcohol use disorder, pain management and opioids, dismantling the stigma, and more.

Even after the initial acute COVID-19 infection has subsided, patients are frequently left with short- or long-term sequelae post-infection. Many of these are similar to the sequelae of other severe pulmonary infections, sepsis, and/or intensive care unit admission. The organ systems affected are numerous and span the entire body. Particularly problematic are the cardiac, pulmonary, neurologic/cognitive, and thromboembolic sequelae. This educational program seeks to increase clinician awareness of these post-COVID-19 symptoms to emphasize the importance of treatment to avoid such outcomes. This is the final module of this series on the outpatient management of patients with COVID-19.

Even after the initial acute COVID-19 infection has subsided, patients are frequently left with short- or long-term sequelae post-infection. Many of these are similar to the sequelae of other severe pulmonary infections, sepsis, and/or intensive care unit admission. The organ systems affected are numerous and span the entire body. Particularly problematic are the cardiac, pulmonary, neurologic/cognitive, and thromboembolic sequelae. This educational program seeks to increase clinician awareness of these post-COVID-19 symptoms to emphasize the importance of treatment to avoid such outcomes. This is the final module of this series on the outpatient management of patients with COVID-19.

Earlier in the COVID-19 pandemic, treatment recommendations for COVID-19 were scattered with new data pouring in. As new treatments were tested, their efficacies were revealed and national guideline recommendations were made accordingly. Given the number of potential treatments, it is essential for clinicians to know the guidelines to treat their patients effectively and prevent poor outcomes. This is the second of three modules on the outpatient management of patients with COVID-19. The focus of this module is on treatment of mild-to-moderate COVID-19.

Earlier in the COVID-19 pandemic, treatment recommendations for COVID-19 were scattered with new data pouring in. As new treatments were tested, their efficacies were revealed and national guideline recommendations were made accordingly. Given the number of potential treatments, it is essential for clinicians to know the guidelines to treat their patients effectively and prevent poor outcomes. This is the second of three modules on the outpatient management of patients with COVID-19. The focus of this module is on treatment of mild-to-moderate COVID-19.